Latent carcinoma of the prostate.

No abstract is available for this paper.

• Publication year

  1954

• Venue

  The Journal of Pathology and Bacteriology

• Publication date

  1954-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/PATH.1700680233PMID 14354564
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Atrophy and hyperplasia in the prostate proper.

  1954cited by this paper
• Latent carcinoma.

  1954cited by this paper
• An autopsy study of latent prostatic cancer

  1953cited by this paper
• Benign nodular hyperplasia of the prostate; a review.

  1953cited by this paper
• Microscopic differential diagnosis of latent carcinoma of prostate.

  1953cited by this paper
• The response of prostatic carcinoma to œstrogen treatment

  1953cited by this paper
• The local action of 20-methylcholanthrene and sex hormones on prostatic grafts.

  1952cited by this paper
• The Local Action of 20-Methylcholanthrene and Sex Hormones on Prostatic Grafts

  1952cited by this paper
• Carcinoma of prostate in young adults.

  1952cited by this paper
• A study of the Golgi material and mitochondria in malignant and benign prostatic tissue.

  1950cited by this paper
• The Effects of Castration and Stilboestrol on Prostatic Tumours in Mice

  1949cited by this paper
• Radical perineal prostatectomy for cancer of the prostate; an analysis of 190 cases.

  1949cited by this paper
• Latent Carcinoma of the Prostate

  1949cited by this paper
• Carcinoma of the prostate; a study of the postmortem findings in 176 cases.

  1948cited by this paper
• Carcinoma of the Prostate: A Study of the Postmortem Findings in One Hundred and Seventy-Six Cases

  1948cited by this paper
• Cancer of the bladder and prostate.

  1947cited by this paper
• The obstructive prostate.

  1947cited by this paper
• The Cure of Cancer of the Prostate by Radical Perineal Prostatectomy (prostato-seminal Vesiculectomy): History, Literature and Statistics of Young’s Peration11Read by title at annual meeting, American Urological Association, St. Louis, Mo., June 20, 1944 and amplified.

  1945cited by this paper
• Carcinoma of the Prostate Gland: A Pathologic Study

  1939cited by this paper
• The Morphology of Small Prostatic Carcinoma1

  1935cited by this paper
• On The Frequency of Occurrence of Occult Carcinoma of the Prostate1

  1935cited by this paper

• Does a Negative Prostate Biopsy Reduce the Risk of Prostate Cancer Reclassification in an Active Surveillance Protocol? An Updated Systematic Review and Meta‐Analysis

  2025cites this paper
• Y-chromosome alteration and its impact on cancer progression and metastasis

  2025cites this paper
• Exploring the Link Between Obligate Anaerobe-Related Dysbiosis and Prostate Cancer Development: A Pilot Study

  2024cites this paper
• Mucins as Potential Biomarkers for Early Detection of Cancer

  2023cites this paper
• Effects of chemotherapy in cancer patients

  2022cites this paper
• Global Trends of Latent Prostate Cancer in Autopsy Studies

  2021cites this paper
• Milestones in the management of prostate cancer

  2021cites this paper
• Complications of transrectal prostate biopsy in our context. International multicenter study of 3350 patients.

  2020cites this paper
• Complications of transrectal prostate biopsy in our context. International multicenter study of 3350 patients

  2020cites this paper
• "More men die with prostate cancer than because of it" - an old adage that still holds true in the 21st century.

  2020cites this paper
• Multiparametric and multidimensional: a three-dimensional and multiparametric approach to ultrasound imaging of prostate cancer

  2019cites this paper
• Incidence of Carcinoma Prostate in Cases of Benign Prostatic Hyperplasia in Rims Ranchi Jharkhand

  2019influential citation
• Erhöhtes PSA – wie weiter?

  2019cites this paper
• The history of urologic pathology: an overview

  2019cites this paper
• Proteomics in Prostate Cancer Research

  2018cites this paper
• Clinical outcomes for men diagnosed with prostate cancer

  2018cites this paper
• Prostate Cancer in Deceased Organ Donors: Loss of Organ or Transplantation With Active Surveillance.

  2018cites this paper
• Prevalence of Clinically Concealed Prostatic Diseases at Post Mortem; a Teaching Hospital Experience in South-South, Nigeria

  2018cites this paper
• Stopping screening, when and how?

  2018cites this paper
• Being on active surveillance: the patient perspective

  2018cites this paper
• Feedback regulation loop between bonemorphogenetic proteins and theirantagonists in prostate cancer and theimplication in bone metastasis

  2018cites this paper
• Defining clinically significant prostate cancer on the basis of pathological findings

  2018cites this paper
• Zusammenhang der NY-ESO-1 Expression zur TMPRSS2:ERG-Genfusion beim Prostatakrebs

  2017cites this paper
• PSA-Screening: Wie viel Nutzen bei welchen Kosten?

  2017cites this paper
• Prostatic adenocarcinoma and prostatic intraepithelial neoplasia: A tale of the autopsy model in a Nigerian tertiary hospital

  2017influential citation
• Identification and evaluation of clinically significant prostate cancer: a step towards personalized diagnosis

  2017cites this paper
• Histopathologic Pattern of Prostatic Lesions Observed in Autopsy Series

  2017cites this paper
• Modélisation du cancer de la prostate par l'imagerie : détection, stratification, planning thérapeutique et suivi en 3D d'une thérapie focale basés sur le recalage-fusion d'image en multi modalité

  2017cites this paper
• Screening for familial and hereditary prostate cancer

  2016cites this paper
• Prostate cancer: Can I have a PSA test please nurse?

  2016cites this paper
• Importance of Estrogenic Signaling and Its Mediated Receptors in Prostate Cancer

  2016cites this paper
• The molecular and cellular origin of human prostate cancer.

  2016cites this paper
• The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate‐specific Antigen‐era

  2015cites this paper
• The histomorphological study of prostate lesions

  2015cites this paper
• Prevalence of incidental prostate cancer: A systematic review of autopsy studies

  2015cites this paper
• Is There a Role for Active Surveillance in Low-Risk Prostate Cancer?

  2015cites this paper
• Individuelles Risiko-adaptiertes PSA-Screening

  2015cites this paper
• A "PSA pyramid" for men with initial prostate-specific antigen ≤3 ng/ml: a plea for individualized prostate cancer screening.

  2015cites this paper
• Childhood height increases the risk of prostate cancer mortality.

  2015cites this paper
• Dépistage individuel par dosage du PSA en fonction des risques

  2015cites this paper
• Is further screening of men with baseline PSA < 1 ng ml−1 worthwhile? The discussion continues—Results of the Swiss ERSPC (Aarau)

  2015influential citation
• High RhoA expression at the tumor front in clinically localized prostate cancer and association with poor tumor differentiation

  2015cites this paper
• Cancer research in need of a scientific revolution: Using ‘paradigm shift’ as a method of investigation

  2015influential citation
• Cancer research in need of a scientific revolution: Using ‘paradigm shift’ as a method of investigation

  2015influential citation
• Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy

  2015cites this paper
• Characteristics of screen-failures in prostate cancer screening

  2015cites this paper
• INCIDENCE AND CLINICAL COURSE OF INCIDENTAL PROSTATIC ADENOCARCINOMA: A PROSPECTIVE INDIAN STUDY A Prospective

  2015cites this paper
• A study on the prevalence of prostatic cancer among forensic autopsy cases

  2015cites this paper
• Perspectives on Screening

  2014cites this paper
• Development and evaluation of nanoparticles for cancer treatment

  2014cites this paper
• Key papers in prostate cancer

  2014cites this paper
• Temporal trends and racial disparities in global prostate cancer prevalence.

  2014cites this paper
• Estimating age and ethnic variation in the histological prevalence of prostate cancer to inform the impact of screening policies

  2014cites this paper
• Nanomedicine and its applications to the treatment of prostate cancer.

  2014cites this paper
• International perspectives on screening.

  2014cites this paper
• Bringing androgens up a NOTCH in breast cancer.

  2014cites this paper
• Gleason 6 prostate tumors diagnosed in the PSA era do not demonstrate the capacity for metastatic spread at the time of radical prostatectomy.

  2013cites this paper
• Low Risk Prostate Cancer and Active Surveillance

  2013cites this paper
• The perils of overdiagnosis

  2013cites this paper
• Incidence of Sub-Clinical Prostatic Disease at Autopsy in the University College Hospital, Ibadan

  2013cites this paper
• Active surveillance for low-risk prostate cancer.

  2013cites this paper
• The Age Specific Incidence Anomaly Suggests that Cancers Originate During Development

  2013cites this paper
• Preneoplasia in the prostate gland with emphasis on high grade prostatic intraepithelial neoplasia

  2013cites this paper
• A genome-wide association study of prostate cancer in West African men

  2013cites this paper
• Coming up for air: follow-up and risk stratification after negative prostate cancer screening.

  2013influential citation
• Incidence of SubClinical Prostatic Disease at Autopsy in the University College Hospital , Ibadan

  2013cites this paper
• Childhood Height and Birth Weight in Relation to Future Prostate Cancer Risk: A Cohort Study Based on the Copenhagen School Health Records Register

  2013cites this paper
• Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men.

  2013cites this paper
• Defining the threshold for significant versus insignificant prostate cancer

  2013cites this paper
• Number of screens for overdetection as an indicator of absolute risk of overdiagnosis in prostate cancer screening

  2012cites this paper
• Prostate cancer: is it all just hype?

  2012cites this paper
• Current Challenges in Prostate Cancer Management and the Rationale behind Targeted Focal Therapy

  2012cites this paper
• Can a Gleason 6 or Less Microfocus of Prostate Cancer in One Biopsy and Prostate-Specific Antigen Level <10 ng/mL Be Defined as the Archetype of Low-Risk Prostate Disease?

  2012cites this paper
• Ligand-independent activation of EphA2 by arachidonic acid induces metastasis-like behaviour in prostate cancer cells

  2012cites this paper
• A CHEMOPREVENTIVE FACTOR IN PROSTATE CANCER

  2012cites this paper
• Clinical Utility of Laboratory Tests

  2012cites this paper
• Changes in the location of oxytocin receptor in the human prostate

  2012cites this paper
• Is population screening for prostate cancer good or bad?

  2011cites this paper
• Quality of life and genetics in men with prostate cancer

  2011cites this paper
• Screening for prostate cancer.

  2011cites this paper
• [Batson's paravertebral venous plexus and single vertebral metastases from renal cell carcinoma].

  2010cites this paper
• Nomogram to Predict Insignificant Prostate Cancer at Radical Prostatectomy in Korean Men: A Multi-Center Study

  2010cites this paper
• Prostate cancer incidence among men using statins, finasteride or antidiabetic drugs

  2009cites this paper
• "Benign essential" prostate cancer?

  2009cites this paper
• Cancer screenings, diagnostic technology evolution, and cancer control.

  2009cites this paper
• Influence of omega-6 PUFA arachidonic acid and bone marrow adipocytes on metastatic spread from prostate cancer

  2009influential citation
• Knowledge and utilization of prostate specific antigen test assay: a regional questionnaire study.

  2008cites this paper
• Defining the Problem: From Subclinical Disease to Clinically Insignificant Prostate Cancer

  2008cites this paper
• Screening for Prostate Cancer: Digital rectal examination: outdated or still valuable?

  2008cites this paper
• Do Clinically Insignificant Tumors of the Prostate Exist?

  2008cites this paper
• Statins and prostate cancer prevention: where we are now, and future directions

  2008cites this paper
• IMMUNO-GENE THERAPY FOR METASTATIC PROSTATE CANCER

  2008cites this paper
• Histopathology and Molecular Biology of Prostate Atrophy

  2008cites this paper
• Die Epidemiologie des Prostatakarzinoms

  2008cites this paper
• Inflammation as the primary aetiological agent of human prostate cancer: A stem cell connection?

  2008cites this paper
• Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillance

  2008cites this paper
• Commentary: prostate cancer is omnipresent, but should we screen for it?

  2007cites this paper
• Teile dieser Arbeit wurden in den folgenden Arbeiten publiziert

  2007cites this paper
• Atorvastatin and Celecoxib Inhibit Prostate PC-3 Tumors in Immunodeficient Mice

  2007cites this paper
• The value of prognostic factors in prostatic cancer

  2007cites this paper